The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has
increased among the general population and chronic hepatitis B (CHB) patients worldwide …

Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic
factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver …

Metabolic dysfunction-associated fatty liver disease (MAFLD) has now affected nearly one-
third of the global population and has become the number one cause of chronic liver …

Background Whether serum hepatitis B virus (HBV) RNA associates with hepatocellular
carcinoma (HCC) development in chronic hepatitis B (CHB) patients has not been fully …

原发性肝癌是世界上常见的恶性肿瘤之一, 具有较高的发病率和死亡率. 本文详述了目前我国原
发性肝癌的流行病学情况, 人群归因分值及其相关危险因素. 本文通过检索PubMed, Web of …

Fatty liver disease and chronic hepatitis B (CHB) are the major causes for chronic liver
diseases and the associated adverse outcomes. Concurrent hepatic steatosis has been …

Background and aims Adiposity is associated with an increased risk of primary liver cancer
(PLC). As the most commonly used indicator of adiposity, the body mass index (BMI) has …

Methods Histologically-proven CHB receiving first-line antiviral regimens as initial therapy
was enrolled and grouped by the concurrence of NAFLD, and followed up at six monthly …

With the wide use of potent and safe nucloes (t‐) ide analogues (NAs) treatment, patient‐
centered care is getting important. Intensive care for comorbidity has gain utmost importance …

BACKGROUND Although the prognostic relevance of sarcopenia has been increasingly
recognised in the context of liver disease, there is a paucity of data evaluating body …